Press Releases Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.51 ^USD	-5.62%		-15.17%	-43.45%

Apr. 01	Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer	CI
Mar. 19	Transcript : Cyclacel Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 19, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cyclacel Pharmaceuticals : April 2024 Corporate Presentation	Apr. 02	PU
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Mar. 20	AQ
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be presented at the American Association for Cancer Research Annual Meeting 2024	Mar. 08	AQ
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit	Mar. 07	AQ
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO and Investor Conference	Feb. 21	AQ
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer	Jan. 31	AQ
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024	Jan. 03	AQ
Cyclacel Receives Notification of Deficiency from Nasdaq Regarding Timely Filing of Quarterly Report on Form 10-Q	Nov. 29	AQ
Cyclacel Pharmaceuticals : September 2023 Corporate Presentation	23-09-15	PU
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update	23-08-10	AQ
CYCLACEL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	23-06-14	AQ
Cyclacel Pharmaceuticals : March 2023 Corporate Presentation	23-06-13	PU
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update	23-05-12	AQ
CYCLACEL PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
CYCLACEL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-05-04	AQ
Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit	23-05-04	AQ
Cyclacel Pharmaceuticals : March 2023 Corporate Presentation	23-03-28	PU
CYCLACEL PHARMACEUTICALS, INC. : Regulation FD Disclosure (form 8-K)	23-03-13	AQ
Cyclacel Pharmaceuticals : March 2023 Corporate Presentation	23-03-12	PU
CYCLACEL PHARMACEUTICALS, INC. : Other Events (form 8-K)	23-03-09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cyclacel Pharmaceuticals, Inc.

Equities

CYCC

US23254L8019

Press Releases

Filters